This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.
Volastra Therapeutics has been bullish about KIF18A as a solid tumor drug target...
Merus completed its rollout of Phase 2 head and neck cancer data on Thursday, to...
GSK’s blockbuster respiratory drug Nucala was approved Thursday for certain pati...
A drug from Jazz Pharmaceuticals that has yet to read out confirmatory data in l...
The final overall survival results are in for Roche’s PI3K inhibitor, known as I...
Hinge Health shares {$HNGE} ended its first day of trading up 18%, setting the t...
Almost two years ago, Vinay Prasad called a meeting of FDA vaccine advisors a “s...
The House of Representatives on Thursday morning passed President Donald Trump’s...
FDA Commissioner Marty Makary defended thousands of staff cuts during his first ...
Hinge Health shares {$HNGE} jumped 23% in its first day trading as a public comp...
The sun is setting on compounding pharmacies’ ability to make copies of hot weig...
Welcome to Endpoints News’ manufacturing briefs, where we bring you essential ne...
The White House released its MAHA Commission report, detailing some of the Trump...
Every year, the venture firm Venrock conducts its annual “Healthcare Prognosis” ...
Endpoints News is moving to a new website domain on June 1, 2025. The front door...